Showing results (2021-2030 of 2,089) with videos related to
Sort By:
Pageof 209
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017William G Wierda, Andrew D Zelenetz, Leo I Gordon, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Diffuse Large B-Cell Lymphoma Version 1.2016Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.The Lancet. Haematology|April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignanciesGita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.The Lancet. Haematology|June 17, 2018
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignanciesGita Thanarajasingam, Lori M Minasian, Frederic Baron, et al.Nature Medicine|June 30, 2018
Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomesBjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.Nature Medicine|May 2, 2018
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomesBjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.Nature Medicine|June 30, 2018
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomesBjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.The American Journal of Clinical Nutrition|March 5, 2021
Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: results from the FOCUS consortiumJanna L Koole, Martijn J L Bours, Anne J M R Geijsen, et al.Pageof 209